Evidence map›Paper›PMID 32512151›Full record

ArticleNeurobiology of disease2020

Disrupted inhibitory plasticity and homeostasis in Fragile X syndrome.

C A Cea-Del Rio, A Nunez-Parra, S M Freedman, J K Kushner, A L Alexander, D Restrepo, M M Huntsman

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

C A Cea-Del RioDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America; CIBAP, Escuela de Medicina, Facultad de Ciencias Medicas, Universidad de Santiago de Chile, Santiago, Chile; University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America.
A Nunez-ParraDepartment of Cell and Developmental Biology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America; Department of Biology, Universidad de Chile, Santiago, Chile.
S M FreedmanDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America.
J K KushnerDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America; Department of Neurosurgery, School of Medicine, Anschutz Medical Campus, Aurora, CO, United States of America.
A L AlexanderDepartment of Neurosurgery, School of Medicine, Anschutz Medical Campus, Aurora, CO, United States of America.
D RestrepoDepartment of Cell and Developmental Biology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America.
M M HuntsmanDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America; Department of Pediatrics, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States of America. Electronic address: Molly.Huntsman@CUAnschutz.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Chile · CL

Funding

PERIPHERAL MECHANISMS OF OLFACTORY RECEPTIONR01DC000566 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI RESTREPO, DIEGO · 1989 to 2022
$9.9M
Cortical circuit dysfunction in fragile x syndromeR01NS095311 · NINDS · UNIVERSITY OF COLORADO DENVER · PI HUNTSMAN, MOLLY-MAUREEN · 2015 to 2018
$1.4M
NIDCD NIH HHS R01 DC000566NINDS NIH HHS R01 NS095311
6 · The paper itself

Abstract

Fragile X Syndrome (FXS) is a neurodevelopmental disorder instigated by the absence of a key translation regulating protein, Fragile X Mental Retardation Protein (FMRP). The loss of FMRP in the CNS leads to abnormal synaptic development, disruption of critical periods of plasticity, and an overall deficiency in proper sensory circuit coding leading to hyperexcitable sensory networks. However, little is known about how this hyperexcitable environment affects inhibitory synaptic plasticity. Here, we show that in vivo layer 2/3 of the primary somatosensory cortex of the Fmr1 KO mouse exhibits basal hyperexcitability and an increase in neuronal firing rate suppression during whisker activation. This aligns with our in vitro data that indicate an increase in GABAergic spontaneous activity, a faulty mGluR-mediated inhibitory input and impaired inhibitory plasticity processes. Specifically, we find that mGluR activation sensitivity is overall diminished in the Fmr1 KO mouse leading to both a decreased spontaneous inhibitory postsynaptic input to principal cells and a disrupted form of inhibitory long-term depression (I-LTD). These data suggest an adaptive mechanism that acts to homeostatically counterbalance the cortical hyperexcitability observed in FXS.

Indexed as

AnimalsDisease Models, AnimalExcitatory Postsynaptic PotentialsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHomeostasisInhibitory Postsynaptic PotentialsMiceMice, KnockoutNeural InhibitionNeuronal PlasticityPyramidal CellsSomatosensory CortexFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1CortexFragile X syndromeInhibitory neurotransmissionInterneuronsPlasticity

Identifiers

PMID32512151
PMCPMC7959200
OpenAlexW3033701340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.